$PPBT 99.6% of short shares are used. And the price still keeps rising. Nt-219 is the fucking honey badger of cancer drugs. It will succeed wether you retardedly short this company or not. So you only have yourself to blame when you lose your house over shorting a drug like the one they have. Monotherapy data due any day. Our eyes are on March 8-9 conference.